All In MedTech

FDA Clearance Tracker · P200015-S020

Edwards Alterra Adaptive Prestent System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 8, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 8, 2022

Approved

Time to decision

105 days

Received Apr 25, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

The decision

FDA number
P200015-S020
Device name
Edwards Alterra Adaptive Prestent System
Applicant location
Irvine, CA
Received
Apr 25, 2022
Decided
Aug 8, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P200015

Device type

Every decision under product code NPV

FDA's approval statement

As written in FDA's record.

Approval for a new e-beam sterilizer for the Alterra Adaptive Prestent System.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.